Eleven Biotherapeutics Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eleven Biotherapeutics Inc with three other
companies in this sector in the United States:
Five Prime Therapeutics Inc
sales of $30.69 million
Blueprint Medicines Corp
of which 100%
was Biopharmaceutical), and
of which 91%
was Gevo Development/Agri-Energy).